Beam Therapeutics BEAM has been analyzed by 9 analysts in the last three months, revealing a diverse range of perspectives ...
Reversal from long-term demand zone starting on March 11. The next significant resistance is at the $0.010 area. More upside ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback